Clinical Trial Update: Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs [Phase 3]

View source ↗

Summary

A multi-center Phase 3 randomized trial evaluating SkinTE® for Wagner 2 diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• SkinTE

Snippet

Sponsor: PolarityTE | Conditions: Diabetic Foot | Phase 3 | Status: TERMINATED